STEVEN MARK FOGELMAN
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry
- Where
- ROME, NY
- NPI
- 1821137712
- Received
- $383,177 in 470 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 77 | $79,496 |
| 2024 | General payment | 57 | $40,489 |
| 2023 | General payment | 81 | $62,317 |
| 2022 | General payment | 98 | $91,924 |
| 2021 | General payment | 70 | $64,949 |
| 2020 | General payment | 23 | $20,341 |
| 2019 | General payment | 64 | $23,658 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Avanir Pharmaceuticals, Inc. | 172 | $146,752 | 2019–2022 |
| Neurocrine BioSciences, Inc. | 100 | $94,754 | 2023–2025 |
| ABBVIE INC. | 76 | $79,437 | 2021–2025 |
| Otsuka America Pharmaceutical, Inc. | 62 | $43,676 | 2019–2024 |
| Allergan, Inc. | 46 | $17,578 | 2019–2020 |
| Axsome Therapeutics, Inc. | 8 | $495 | 2023–2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $351 | 2021–2025 |
| Janssen Pharmaceuticals, Inc | 1 | $90 | 2019 |
| UCB, Inc. | 1 | $27 | 2019 |
| ACADIA Pharmaceuticals Inc | 1 | $14 | 2019 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 142 | $319,990 |
| Travel and Lodging | 149 | $33,760 |
| Consulting Fee | 3 | $17,837 |
| Food and Beverage | 171 | $11,465 |
| Education | 5 | $124 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-11-07 | Neurocrine BioSciences, Inc. | $3,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-11-07 | Neurocrine BioSciences, Inc. | $189 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-08-08 | Neurocrine BioSciences, Inc. | $3,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-08-08 | Neurocrine BioSciences, Inc. | $516 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-08-08 | Neurocrine BioSciences, Inc. | $179 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-08-08 | Neurocrine BioSciences, Inc. | $91 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-08-08 | Neurocrine BioSciences, Inc. | $39 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-08-04 | Neurocrine BioSciences, Inc. | $25 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-07-01 | Neurocrine BioSciences, Inc. | $22 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-06-30 | Neurocrine BioSciences, Inc. | $3,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-06-30 | Neurocrine BioSciences, Inc. | $182 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-06-25 | Axsome Therapeutics, Inc. | $57 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-06-18 | Neurocrine BioSciences, Inc. | $3,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-06-18 | Neurocrine BioSciences, Inc. | $165 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-05-21 | Neurocrine BioSciences, Inc. | $3,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-05-21 | Neurocrine BioSciences, Inc. | $287 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-05-21 | Neurocrine BioSciences, Inc. | $156 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-05-21 | Neurocrine BioSciences, Inc. | $109 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-05-16 | Neurocrine BioSciences, Inc. | $3,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-05-16 | Neurocrine BioSciences, Inc. | $414 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-05-16 | Neurocrine BioSciences, Inc. | $313 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-05-15 | Neurocrine BioSciences, Inc. | $19 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-05-14 | Neurocrine BioSciences, Inc. | $3,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-05-14 | Neurocrine BioSciences, Inc. | $88 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-04-29 | ABBVIE INC. | $3,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-04-11 | ABBVIE INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-04-11 | ABBVIE INC. | $1,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-04-11 | Neurocrine BioSciences, Inc. | $15 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-04-10 | Neurocrine BioSciences, Inc. | $3,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-04-03 | Neurocrine BioSciences, Inc. | $6,400 | Consulting Fee | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-04-03 | ABBVIE INC. | $172 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-04-03 | ABBVIE INC. | $125 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-27 | Neurocrine BioSciences, Inc. | $3,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-27 | Neurocrine BioSciences, Inc. | $340 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-27 | Neurocrine BioSciences, Inc. | $138 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-27 | Neurocrine BioSciences, Inc. | $112 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-19 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-18 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $124 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-03-12 | Neurocrine BioSciences, Inc. | $3,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-12 | Neurocrine BioSciences, Inc. | $326 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-12 | Neurocrine BioSciences, Inc. | $98 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-09 | Neurocrine BioSciences, Inc. | $843 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-09 | Neurocrine BioSciences, Inc. | $77 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-08 | Neurocrine BioSciences, Inc. | $141 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-08 | Neurocrine BioSciences, Inc. | $61 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-08 | Neurocrine BioSciences, Inc. | $54 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-08 | Neurocrine BioSciences, Inc. | $37 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-08 | Neurocrine BioSciences, Inc. | $32 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-08 | Neurocrine BioSciences, Inc. | $9 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-08 | Neurocrine BioSciences, Inc. | $6 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-07 | Neurocrine BioSciences, Inc. | $485 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-07 | Neurocrine BioSciences, Inc. | $179 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-07 | Neurocrine BioSciences, Inc. | $175 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-07 | Neurocrine BioSciences, Inc. | $66 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-07 | Neurocrine BioSciences, Inc. | $53 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-04 | ABBVIE INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-02-27 | Neurocrine BioSciences, Inc. | $3,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-02-27 | Neurocrine BioSciences, Inc. | $168 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-02-27 | Neurocrine BioSciences, Inc. | $116 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-02-19 | ABBVIE INC. | $62 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-02-19 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-02-14 | Neurocrine BioSciences, Inc. | $125 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-02-11 | ABBVIE INC. | $3,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-02-11 | ABBVIE INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-02-04 | ABBVIE INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-01-31 | Neurocrine BioSciences, Inc. | $30 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-01-30 | Neurocrine BioSciences, Inc. | $2,438 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-01-30 | Neurocrine BioSciences, Inc. | $23 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-01-29 | Neurocrine BioSciences, Inc. | $2,438 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-01-28 | Neurocrine BioSciences, Inc. | $3,563 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-01-28 | ABBVIE INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-01-28 | Neurocrine BioSciences, Inc. | $142 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-01-28 | Neurocrine BioSciences, Inc. | $121 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-01-23 | ABBVIE INC. | $158 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-01-23 | ABBVIE INC. | $125 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-01-21 | ABBVIE INC. | $114 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-01-21 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2024-11-19 | ABBVIE INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-11-14 | Neurocrine BioSciences, Inc. | $2,438 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-11-14 | Neurocrine BioSciences, Inc. | $115 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-10-28 | ABBVIE INC. | $79 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-09-19 | Neurocrine BioSciences, Inc. | $138 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-09-03 | Neurocrine BioSciences, Inc. | $22 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-08-27 | ABBVIE INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-08-21 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $126 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-07-30 | ABBVIE INC. | $75 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-06-18 | Axsome Therapeutics, Inc. | $125 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-05-08 | Otsuka America Pharmaceutical, Inc. | $61 | Travel and Lodging | Cash or cash equivalent | NUEDEXTA Drug, NEUROLOGY | 2024 | |
| 2024-05-08 | Otsuka America Pharmaceutical, Inc. | $53 | Travel and Lodging | Cash or cash equivalent | NUEDEXTA Drug, NEUROLOGY | 2024 | |
| 2024-05-08 | Otsuka America Pharmaceutical, Inc. | $36 | Travel and Lodging | Cash or cash equivalent | NUEDEXTA Drug, NEUROLOGY | 2024 | |
| 2024-05-01 | Otsuka America Pharmaceutical, Inc. | $189 | Travel and Lodging | Cash or cash equivalent | NUEDEXTA Drug, NEUROLOGY | 2024 | |
| 2024-05-01 | Otsuka America Pharmaceutical, Inc. | $189 | Travel and Lodging | Cash or cash equivalent | NUEDEXTA Drug, NEUROLOGY | 2024 | |
| 2024-04-25 | Neurocrine BioSciences, Inc. | $2,438 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-04-24 | Otsuka America Pharmaceutical, Inc. | $2,948 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NUEDEXTA Drug, NEUROLOGY | 2024 | |
| 2024-04-24 | Otsuka America Pharmaceutical, Inc. | $1,742 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NUEDEXTA Drug, NEUROLOGY | 2024 | |
| 2024-04-24 | Otsuka America Pharmaceutical, Inc. | $351 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NUEDEXTA Drug, NEUROLOGY | 2024 | |
| 2024-04-21 | Otsuka America Pharmaceutical, Inc. | $149 | Travel and Lodging | In-kind items and services | NUEDEXTA Drug, NEUROLOGY | 2024 | |
| 2024-04-18 | Otsuka America Pharmaceutical, Inc. | $125 | Food and Beverage | In-kind items and services | NUEDEXTA Drug, NEUROLOGY | 2024 | |
| 2024-04-17 | Otsuka America Pharmaceutical, Inc. | $125 | Food and Beverage | In-kind items and services | NUEDEXTA Drug, NEUROLOGY | 2024 | |
| 2024-04-04 | Neurocrine BioSciences, Inc. | $3,563 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-04-04 | Neurocrine BioSciences, Inc. | $312 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-04-04 | Neurocrine BioSciences, Inc. | $124 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-04-03 | Otsuka America Pharmaceutical, Inc. | $2,546 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NUEDEXTA Drug, NEUROLOGY | 2024 | |
| 2024-04-03 | Otsuka America Pharmaceutical, Inc. | $1,742 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NUEDEXTA Drug, NEUROLOGY | 2024 | |
| 2024-04-03 | Otsuka America Pharmaceutical, Inc. | $167 | Travel and Lodging | Cash or cash equivalent | NUEDEXTA Drug, NEUROLOGY | 2024 | |
| 2024-03-29 | Neurocrine BioSciences, Inc. | $34 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-03-27 | Otsuka America Pharmaceutical, Inc. | $125 | Food and Beverage | In-kind items and services | NUEDEXTA Drug, NEUROLOGY | 2024 | |
| 2024-03-26 | Otsuka America Pharmaceutical, Inc. | $121 | Food and Beverage | In-kind items and services | NUEDEXTA Drug, NEUROLOGY | 2024 | |
| 2024-03-22 | Otsuka America Pharmaceutical, Inc. | $1,742 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NUEDEXTA Drug, NEUROLOGY | 2024 | |
| 2024-03-19 | Neurocrine BioSciences, Inc. | $5,437 | Consulting Fee | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-03-13 | Otsuka America Pharmaceutical, Inc. | $702 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NUEDEXTA Drug, NEUROLOGY | 2024 | |
| 2024-03-06 | Otsuka America Pharmaceutical, Inc. | $2,948 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NUEDEXTA Drug, NEUROLOGY | 2024 | |
| 2024-03-02 | Neurocrine BioSciences, Inc. | $239 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-03-02 | Neurocrine BioSciences, Inc. | $175 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-03-02 | Neurocrine BioSciences, Inc. | $51 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-03-02 | Neurocrine BioSciences, Inc. | $43 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-03-02 | Neurocrine BioSciences, Inc. | $28 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-03-02 | Neurocrine BioSciences, Inc. | $24 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-03-02 | Neurocrine BioSciences, Inc. | $14 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-03-01 | Neurocrine BioSciences, Inc. | $124 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-02-29 | Otsuka America Pharmaceutical, Inc. | $117 | Travel and Lodging | In-kind items and services | NUEDEXTA Drug, NEUROLOGY | 2024 | |
| 2024-02-29 | Otsuka America Pharmaceutical, Inc. | $16 | Food and Beverage | In-kind items and services | NUEDEXTA Drug, NEUROLOGY | 2024 | |
| 2024-02-28 | Otsuka America Pharmaceutical, Inc. | $117 | Travel and Lodging | In-kind items and services | NUEDEXTA Drug, NEUROLOGY | 2024 | |
| 2024-02-28 | Otsuka America Pharmaceutical, Inc. | $82 | Food and Beverage | In-kind items and services | NUEDEXTA Drug, NEUROLOGY | 2024 | |
| 2024-02-25 | Otsuka America Pharmaceutical, Inc. | $140 | Travel and Lodging | In-kind items and services | NUEDEXTA Drug, NEUROLOGY | 2024 | |
| 2024-02-25 | Otsuka America Pharmaceutical, Inc. | $140 | Travel and Lodging | In-kind items and services | NUEDEXTA Drug, NEUROLOGY | 2024 | |
| 2024-02-07 | Axsome Therapeutics, Inc. | $103 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-02-07 | Axsome Therapeutics, Inc. | $21 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-02-07 | Axsome Therapeutics, Inc. | $5 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-01-24 | Neurocrine BioSciences, Inc. | $27 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-01-22 | Neurocrine BioSciences, Inc. | $132 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-01-10 | Neurocrine BioSciences, Inc. | $3,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-01-10 | Neurocrine BioSciences, Inc. | $174 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-01-10 | Neurocrine BioSciences, Inc. | $110 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2023-12-14 | Axsome Therapeutics, Inc. | $104 | Food and Beverage | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-11-30 | Neurocrine BioSciences, Inc. | $2,438 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-11-30 | Neurocrine BioSciences, Inc. | $125 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-11-29 | Neurocrine BioSciences, Inc. | $3,563 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-11-29 | Neurocrine BioSciences, Inc. | $165 | Travel and Lodging | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-11-29 | Neurocrine BioSciences, Inc. | $116 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-11-20 | Axsome Therapeutics, Inc. | $43 | Education | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-11-20 | Axsome Therapeutics, Inc. | $35 | Education | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-11-01 | Neurocrine BioSciences, Inc. | $2,438 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-11-01 | Neurocrine BioSciences, Inc. | $131 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-10-04 | Otsuka America Pharmaceutical, Inc. | $1,742 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NUEDEXTA Drug, NEUROLOGY | 2023 | |
| 2023-09-27 | Otsuka America Pharmaceutical, Inc. | $2,948 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NUEDEXTA Drug, NEUROLOGY | 2023 | |
| 2023-09-27 | Otsuka America Pharmaceutical, Inc. | $86 | Food and Beverage | In-kind items and services | NUEDEXTA Drug, NEUROLOGY | 2023 | |
| 2023-09-21 | Otsuka America Pharmaceutical, Inc. | $156 | Travel and Lodging | In-kind items and services | NUEDEXTA Drug, NEUROLOGY | 2023 | |
| 2023-09-20 | Otsuka America Pharmaceutical, Inc. | $1,742 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NUEDEXTA Drug, NEUROLOGY | 2023 | |
| 2023-09-19 | Otsuka America Pharmaceutical, Inc. | $542 | Travel and Lodging | In-kind items and services | NUEDEXTA Drug, NEUROLOGY | 2023 | |
| 2023-09-19 | Otsuka America Pharmaceutical, Inc. | $124 | Food and Beverage | In-kind items and services | NUEDEXTA Drug, NEUROLOGY | 2023 | |
| 2023-09-13 | Otsuka America Pharmaceutical, Inc. | $93 | Food and Beverage | In-kind items and services | NUEDEXTA Drug, NEUROLOGY | 2023 | |
| 2023-08-25 | Otsuka America Pharmaceutical, Inc. | $2,948 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NUEDEXTA Drug, NEUROLOGY | 2023 | |
| 2023-08-24 | Otsuka America Pharmaceutical, Inc. | $140 | Travel and Lodging | In-kind items and services | NUEDEXTA Drug, NEUROLOGY | 2023 | |
| 2023-08-22 | Otsuka America Pharmaceutical, Inc. | $602 | Travel and Lodging | In-kind items and services | NUEDEXTA Drug, NEUROLOGY | 2023 | |
| 2023-08-11 | Otsuka America Pharmaceutical, Inc. | $2,948 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NUEDEXTA Drug, NEUROLOGY | 2023 | |
| 2023-08-04 | Otsuka America Pharmaceutical, Inc. | $159 | Travel and Lodging | Cash or cash equivalent | NUEDEXTA Drug, NEUROLOGY | 2023 | |
| 2023-08-04 | Otsuka America Pharmaceutical, Inc. | $159 | Travel and Lodging | Cash or cash equivalent | NUEDEXTA Drug, NEUROLOGY | 2023 | |
| 2023-08-03 | Otsuka America Pharmaceutical, Inc. | $199 | Travel and Lodging | In-kind items and services | NUEDEXTA Drug, NEUROLOGY | 2023 | |
| 2023-08-02 | Otsuka America Pharmaceutical, Inc. | $2,948 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NUEDEXTA Drug, NEUROLOGY | 2023 | |
| 2023-07-28 | Otsuka America Pharmaceutical, Inc. | $162 | Travel and Lodging | In-kind items and services | NUEDEXTA Drug, NEUROLOGY | 2023 | |
| 2023-07-26 | Otsuka America Pharmaceutical, Inc. | $101 | Food and Beverage | In-kind items and services | NUEDEXTA Drug, NEUROLOGY | 2023 | |
| 2023-07-21 | Otsuka America Pharmaceutical, Inc. | $2,948 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NUEDEXTA Drug, NEUROLOGY | 2023 | |
| 2023-07-21 | Otsuka America Pharmaceutical, Inc. | $45 | Travel and Lodging | Cash or cash equivalent | NUEDEXTA Drug, NEUROLOGY | 2023 | |
| 2023-07-21 | Otsuka America Pharmaceutical, Inc. | $34 | Travel and Lodging | Cash or cash equivalent | NUEDEXTA Drug, NEUROLOGY | 2023 | |
| 2023-07-21 | Otsuka America Pharmaceutical, Inc. | $29 | Travel and Lodging | Cash or cash equivalent | NUEDEXTA Drug, NEUROLOGY | 2023 | |
| 2023-06-26 | Otsuka America Pharmaceutical, Inc. | $336 | Travel and Lodging | In-kind items and services | NUEDEXTA Drug, NEUROLOGY | 2023 | |
| 2023-06-25 | Otsuka America Pharmaceutical, Inc. | $1,349 | Travel and Lodging | In-kind items and services | NUEDEXTA Drug, NEUROLOGY | 2023 | |
| 2023-06-13 | ABBVIE INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-06-13 | ABBVIE INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-06-05 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-05-31 | ABBVIE INC. | $85 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-05-31 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-05-30 | ABBVIE INC. | $65 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-05-30 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-05-12 | Otsuka America Pharmaceutical, Inc. | $30 | Travel and Lodging | Cash or cash equivalent | NUEDEXTA Drug, NEUROLOGY | 2023 | |
| 2023-05-05 | Otsuka America Pharmaceutical, Inc. | $2,667 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NUEDEXTA Drug, NEUROLOGY | 2023 | |
| 2023-05-05 | Otsuka America Pharmaceutical, Inc. | $351 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NUEDEXTA Drug, NEUROLOGY | 2023 | |
| 2023-04-14 | Otsuka America Pharmaceutical, Inc. | $551 | Travel and Lodging | In-kind items and services | NUEDEXTA Drug, NEUROLOGY | 2023 | |
| 2023-04-14 | Otsuka America Pharmaceutical, Inc. | $334 | Travel and Lodging | In-kind items and services | NUEDEXTA Drug, NEUROLOGY | 2023 | |
| 2023-04-14 | Otsuka America Pharmaceutical, Inc. | $120 | Travel and Lodging | In-kind items and services | NUEDEXTA Drug, NEUROLOGY | 2023 | |
| 2023-04-14 | Otsuka America Pharmaceutical, Inc. | $67 | Travel and Lodging | In-kind items and services | NUEDEXTA Drug, NEUROLOGY | 2023 | |
| 2023-04-14 | Otsuka America Pharmaceutical, Inc. | $64 | Travel and Lodging | In-kind items and services | NUEDEXTA Drug, NEUROLOGY | 2023 | |
| 2023-04-14 | Otsuka America Pharmaceutical, Inc. | $54 | Travel and Lodging | In-kind items and services | NUEDEXTA Drug, NEUROLOGY | 2023 | |
| 2023-04-14 | Otsuka America Pharmaceutical, Inc. | $42 | Travel and Lodging | In-kind items and services | NUEDEXTA Drug, NEUROLOGY | 2023 | |
| 2023-04-12 | ABBVIE INC. | $3,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-03-28 | ABBVIE INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-03-24 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-03-04 | Neurocrine BioSciences, Inc. | $6,000 | Consulting Fee | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-03-04 | Neurocrine BioSciences, Inc. | $451 | Travel and Lodging | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-03-04 | Neurocrine BioSciences, Inc. | $186 | Travel and Lodging | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-03-04 | Neurocrine BioSciences, Inc. | $70 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-03-04 | Neurocrine BioSciences, Inc. | $53 | Travel and Lodging | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-03-04 | Neurocrine BioSciences, Inc. | $50 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-03-04 | Neurocrine BioSciences, Inc. | $49 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-03-04 | Neurocrine BioSciences, Inc. | $30 | Travel and Lodging | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-03-04 | Neurocrine BioSciences, Inc. | $24 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-03-04 | Neurocrine BioSciences, Inc. | $24 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-03-03 | Neurocrine BioSciences, Inc. | $124 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-03-03 | Neurocrine BioSciences, Inc. | $116 | Travel and Lodging | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2023 |
The latest 200 records of 470.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Rome, NY, county Oneida County, NY, state New York; placed by its city name.
| Measure | Place (city or town) Rome, NY | County Oneida County, NY | State New York |
|---|---|---|---|
| Population B01003 | 31,795 | 229,124 | 19,852,366 |
| Population, 2020 census P1 | 32,127 | 232,125 | 20,201,249 |
| Median age B01002 | 40.7 | 40.7 | 39.8 |
| Under 18 B01001 | 19.5% | 21.4% | 20.5% |
| 65 and over B01001 | 19.8% | 19.8% | 17.9% |
| Households B11001 | 13,870 | 95,220 | 7,722,646 |
| Foreign born B05002 | 3.7% | 8.6% | 22.8% |
| Median household income B19013 | $59,925 | $70,154 | $85,974 |
| Median family income B19113 | $80,180 | $90,731 | $106,873 |
| Per capita income B19301 | $33,321 | $37,903 | $50,712 |
| Poverty rate B17001 | 18.1% | 15.5% | 14.0% |
| Unemployment rate B23025 | 5.9% | 4.6% | 6.4% |
| Civilian labor force B23025 | 13,835 | 107,110 | 10,171,766 |
| Mean commute (minutes) B08013 | 18.0 | 20.6 | 32.6 |
| Bachelor's degree or higher B15003 | 20.8% | 27.8% | 40.2% |
| Housing units B25001 | 15,300 | 105,443 | 8,585,241 |
| Owner-occupied B25003 | 56.6% | 67.7% | 54.3% |
| Renters B25003 | 43.4% | 32.3% | 45.7% |
| Median home value B25077 | $154,400 | $182,600 | $423,800 |
| Median gross rent B25064 | $909 | $944 | $1,621 |
| White, not Hispanic B03002 | 81.0% | 78.7% | 52.8% |
| Black B03002 | 4.4% | 5.7% | 13.4% |
| Hispanic or Latino B03002 | 7.6% | 7.1% | 19.8% |
| Asian B03002 | 1.4% | 4.3% | 9.0% |
| American Indian and Alaska Native B03002 | 0.1% | 0.1% | 0.2% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Rome, NY.
Comments